Essex Financial Services, Inc. Bristol Myers Squibb CO Transaction History

Essex Financial Services, Inc.

$1.33 Billion
Q1 2025

A detailed history of Essex Financial Services, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Essex Financial Services, Inc. holds 53,376 shares of BMY stock, worth $2.51 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

53,376

Previous 50,385 5.94%

Holding current value

$2.51 Million

Previous $2.85 Million 14.25%

% of portfolio

0.25%

Previous 0.21%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$53.9 - $63.11 $161,214 - $188,762	2,991 Added 5.94%	53,376 $3.26 Million
Q4 2024 Jan 29, 2025	SELL	$51.92 - $59.94 $87,692 - $101,238	-1,689 Reduced 3.24%	50,385 $2.85 Million
Q3 2024 Oct 24, 2024	SELL	$39.66 - $51.75 $362,373 - $472,839	-9,137 Reduced 14.93%	52,074 $2.69 Million
Q2 2024 Aug 09, 2024	SELL	$40.25 - $52.99 $106,139 - $139,734	-2,637 Reduced 4.13%	61,211 $2.54 Million
Q2 2024 Jul 31, 2024	BUY	$40.25 - $52.99 $1.3 Million - $1.71 Million	32,236 Added 101.97%	63,848 $2.65 Million
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $99,894 - $113,260	-2,082 Reduced 6.18%	31,612 $1.71 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $244,145 - $291,332	-5,036 Reduced 13.0%	33,694 $1.73 Million
Q3 2023 Nov 15, 2023	SELL	$57.89 - $64.73 $90,482 - $101,172	-1,563 Reduced 3.88%	38,730 $2.25 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $219,926 - $244,194	-3,452 Reduced 7.89%	40,293 $2.58 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $48,625 - $55,152	740 Added 1.72%	43,745 $3.03 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $130,591 - $154,638	1,907 Added 4.64%	43,005 $3.09 Million
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $6 - $3,918	51 Added 0.12%	41,098 $2.92 Million
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $150,613 - $165,878	2,074 Added 5.32%	41,047 $3.16 Million
Q1 2022 Apr 21, 2022	BUY	$61.48 - $73.72 $133,227 - $159,751	2,167 Added 5.89%	38,973 $2.85 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $115,304 - $134,418	-2,150 Reduced 5.52%	36,806 $2.3 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $274,193 - $321,182	4,634 Added 13.5%	38,956 $2.31 Million
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $28,245 - $31,768	-476 Reduced 1.37%	34,322 $2.17 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $46,018 - $52,147	797 Added 2.34%	34,798 $2.16 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $256,022 - $283,707	4,458 Added 15.09%	34,001 $2.05 Million
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $322,396 - $376,913	-5,881 Reduced 16.6%	29,543 $1.74 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $247,868 - $360,211	-5,342 Reduced 13.1%	35,424 $1.98 Million
Q4 2019 Jan 30, 2020	BUY	$49.21 - $64.19 $744,399 - $971,002	15,127 Added 59.0%	40,766 $2.62 Million
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $187,289 - $222,059	-4,379 Reduced 14.59%	25,639 $1.3 Million
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $110,612 - $122,313	-2,479 Reduced 7.63%	30,018 $1.36 Million
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $28,245 - $33,678	-626 Reduced 1.89%	32,497 $1.55 Million
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $315,135 - $408,655	-6,463 Reduced 16.33%	33,123 $1.72 Million
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $783,753 - $884,012	-14,201 Reduced 26.4%	39,586 $2.46 Million
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $676,697 - $843,428	-13,392 Reduced 19.93%	53,787 $2.98 Million
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $697,528 - $802,996	-11,641 Reduced 14.77%	67,179 $4.25 Million
Q4 2017 Feb 07, 2018	SELL	$59.94 - $65.35 $127,911 - $139,456	-2,134 Reduced 2.64%	78,820 $4.83 Million
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $33,966 - $39,200	615 Added 0.77%	80,954 $5.16 Million
Q2 2017 Aug 07, 2017	BUY	N/A	80,339	80,339 $4.48 Million

Others Institutions Holding BMY

# of Institutions

2,806

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.

Account

Essex Financial Services, Inc. Bristol Myers Squibb CO Transaction History